Neoplants raised €20M in a funding round in Oct 2022. The company is based in Paris, France. Investors in the round: Collaborative Fund, Entrepreneur First, Heartcore Capital and 2 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
